Latest biopharmaceutical Stories
BREDA, the Netherlands, June 4, 2014 /PRNewswire/ -- SIGNIFICANTLY EXPANDED RELATIONSHIP CREATED ON BACK OF COLLABORATION SUCCESS arGEN-X, a clinical-stage
SAN DIEGO, June 3, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and
LONDON, May 28, 2014 /PRNewswire/ -- Imperial Innovations Group plc (AIM:IVO, 'Innovations'), the leading technology commercialisation and investment company and S.R.One
CAMBRIDGE, Mass., May 28, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating
LONDON and TORONTO, May 28, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach cytotoxic payloads to alpha fetoprotein PolyTherics Limited ("PolyTherics"),
LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals
Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced the issuing of Patent No.
MONROVIA, Calif., May 22, 2014 /PRNewswire/ -- Xencor, Inc.
Reliable Biopharmaceutical Corporation in partnership with Wilshire Technologies has launched Phytochol®, a vegetal-derived, semi-synthetic cGMP Cholesterol for the Biopharmaceutical market.
DUBLIN, May 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9trl4k/11th_annual)
- A political dynamiter.